Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
about
MR spectroscopy indicates diffuse multiple sclerosis activity during remissionWhite matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosisMRI/MRS in neuroinflammation: methodology and applicationsQuantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypesEvidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processProcedure for quantitative (1)H magnetic resonance spectroscopy and tissue characterization of human brain tissue based on the use of quantitative magnetic resonance imaging.Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.MRI in multiple sclerosis: what's inside the toolbox?Proton magnetic resonance spectroscopy in multiple sclerosis.Advanced MRI in multiple sclerosis: current status and future challengesADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis11C-acetate PET imaging in patients with multiple sclerosis.Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSIEx vivo MR spectroscopic measure differentiates tumor from treatment effects in GBMAxonal damage in multiple sclerosis.Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults.Quantitative T2' imaging in patients with clinically isolated syndromeBrain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.Emerging use of gene expression microarrays in plant physiology.Normal-appearing brain tissue analysis in radiologically isolated syndrome using 3 T MRI.Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.The prognostic utility of MRI in clinically isolated syndrome: a literature review.Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.Higher visceral fat is associated with lower cerebral N-acetyl-aspartate ratios in middle-aged adults.Imaging in multiple sclerosis: A new spin on lesions.Multiple sclerosis animal models: a clinical and histopathological perspective.Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.Which pulse sequence is optimal for myo-inositol detection at 3T?Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.The effects of interferon beta-1a on proton MR spectroscopic imaging in patients with multiple sclerosis, a controlled study, preliminary results.Advanced magnetic resonance imaging in benign hereditary chorea: study of two familial cases.Resting state networks change in clinically isolated syndrome.Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
P2860
Q24615946-4A60944C-F5B9-434A-BAB6-E6A5468DD2AFQ24642079-68051F7C-1335-430B-915E-774545E0129CQ26771930-F1496C35-43D1-4771-B4EB-0B2D4108FAA2Q28299872-C6BF8677-604D-4694-BD53-12313D79579BQ29542960-EA68C71B-D81C-4C62-9E86-6F9DD57E68EFQ30578095-9B065315-265A-4A5A-BA1C-061614729ECEQ30581773-5A6465A1-4BCE-4BC9-8ABA-6FC376C95ED8Q30597559-526AFA6C-D214-4987-8DF8-6997FDF0E5E2Q30992091-25053718-8F9A-4934-BC3A-9E531C6C6E1DQ31027957-1389F410-E41A-4E81-BFB5-AC5AF89052C1Q31037055-A4307CA3-1826-413D-A796-05A7E5B93507Q31132442-553FD5FE-0232-48B7-A64D-A362C41135A3Q33390863-5DB0916D-FB0C-4FC1-9333-2951A0DB3CE8Q33856615-6064922E-B64C-4198-9C96-F33AF541AC1EQ33921391-4D834A3E-4CD1-405C-BB6D-BCD92E2CE9FFQ34427340-2856764B-8C9D-4F37-9810-2C115AE64205Q34450336-FCF5BBA5-D6E2-4542-8C87-2E810CF72AB0Q34548774-57B6D499-37CC-4C3F-A033-382F99BC056FQ34992526-86A682BD-E9E0-477F-B49E-D370E975FC1FQ35126104-EDEFDE68-36A9-44C9-B386-455B115EE8D5Q35810862-9CA2C520-999B-4CB3-BA54-3B47CF20A352Q35980966-522C08B2-43FF-4EF6-83E7-E167B640E945Q36420372-7F17F38C-6394-43F3-ACD5-392554390077Q36748665-A4A0B79D-57FF-493F-A38B-0861BA79EDE6Q37328066-033CE4A7-C12A-4FF2-B273-E997A10BF945Q37334196-5C5514AB-2F09-4805-906F-BEE3E5508928Q38034611-12412B3D-0D5E-4A50-BD77-252794BA2C58Q38211996-293F0369-32EC-4DE9-836E-CC583FD5C8C9Q38374295-158166E2-9385-4832-8369-4A297357C76CQ38638678-AAB1764B-27A6-4F39-A9CA-CE5ABA2BB5B1Q38763488-717B43F5-6D42-4338-B876-32E306EA9EAFQ38910256-A0D484EE-C1F9-4C71-BA9E-42AFB4808653Q38993743-FCAEE6B7-56C7-469C-8F7B-2F4968F40326Q39134746-7D0444B8-00A6-4E26-B1C4-85ED0FA87E5FQ41808736-0B05167A-CAAE-442C-A10F-083C7C1C0B56Q42426175-CA201012-8E13-46F4-9F9B-4FE1BE19D3DEQ42443517-B87500BA-3D8E-4B6F-B235-A3D4E9C62AC5Q42476368-07C26216-A96A-4351-8DC1-C0A97FB74B95Q43587438-EFCECBFC-1CAB-4762-95E7-758400FD252EQ47102673-46F25960-92D7-4D57-A330-4BC0AAA6E434
P2860
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Elevated white matter myo-inos ...... gestive of multiple sclerosis.
@en
type
label
Elevated white matter myo-inos ...... gestive of multiple sclerosis.
@en
prefLabel
Elevated white matter myo-inos ...... gestive of multiple sclerosis.
@en
P2093
P356
P1433
P1476
Elevated white matter myo-inos ...... ggestive of multiple sclerosis
@en
P2093
C M Dalton
D G MacManus
D H Miller
K A Miszkiel
K T M Fernando
M A McLean
R M Gordon
P304
P356
10.1093/BRAIN/AWH153
P407
P577
2004-05-05T00:00:00Z